Germany
Japan
United Kingdom
China
PRKD1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
Proteins
View as table Download
TGFBR1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
ULK1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
MAP3K8 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
EIF2AK3 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
TEK HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
IGF1R HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
USD 134.00
In Stock
ACVR1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
BMPR2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
ERN1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
IRAK4 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
FGFR2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
USD 134.00
In Stock
MAP3K14 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
AURKA HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
ERBB2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
Active filters
Category
-
Proteins
- Over-expression Lysates
Families
- Protein Kinase
Availabilities
- In Stock
Filter by
Target Symbol
- FGFR4 (6)
- AKT1 (5)
- JNK1 (5)
- PCTAIRE1 (5)
- ABL2 (4)
- CAMKK2 (4)
- ERBB 3 (4)
- MST4 (4)
- VRK3 (4)
- ZAK (4)
- AKT3 (3)
- AURORA A (3)
- CAMK1D (3)
- CHK1 (3)
- DDR2 (3)
- EGFR (3)
- ERK1 (3)
- ERK2 (3)
- FES (3)
- FGR (3)
- INSULIN RECEPTOR (3)
- IRAK (3)
- JNK3 (3)
- MCK10 (3)
- NEK11 (3)
- PKC ZETA (3)
- ADCK4 (2)
- ALPK1 (2)
- BRD3 (2)
- C ABL (2)
- CAMK2B (2)
- CAMK2G (2)
- CAMKK (2)
- CASEIN KINASE 1 ALPHA (2)
- CD117 (2)
- CDC42 BINDING PROTEIN KINASE ALPHA (2)
- CDK5 (2)
- CGKI (2)
- CHK2 (2)
- CSK (2)
- CSNK1G1 (2)
- DYRK1B (2)
- DYRK2 (2)
- ERBB 4 (2)
- ERK5 (2)
- FGFR2 (2)
- FYN (2)
- GRK6 (2)
- GSK3 BETA (2)
- HCK (2)
- HER2 (2)
- INTEGRIN LINKED KINASE (2)
- IRAK4 (2)
- IRAKM (2)
- JNK2 (2)
- LIM KINASE 2 (2)
- MAP4K5 (2)
- MEK5 (2)
- MSK1 (2)
- NEK6 (2)
- P38 (2)
- PAK4 (2)
- PAK5 (2)
- PDK3 (2)
- PDPK1 (2)
- PKC DELTA (2)
- PKR (2)
- PYK2 (2)
- RET (2)
- RYK (2)
- SGK1 (2)
- SNRK (2)
- TAOK1 (2)
- TRKA (2)
- TRKB (2)
- TTBK1 (2)
- ULK2 (2)
- A RAF (1)
- ACK1 (1)
- ACTIVIN A RECEPTOR TYPE IB (1)
- ACTIVIN A RECEPTOR TYPE IC (1)
- ACTIVIN RECEPTOR TYPE IA (1)
- ADCK2 (1)
- ADCK3 (1)
- ADCK5 (1)
- AKT2 (1)
- ALK (1)
- ALS2CR2 (1)
- AMHR2 (1)
- AMPK ALPHA 1 (1)
- AMPK ALPHA 2 (1)
- ANKK1 (1)
- ARK5 (1)
- ASK1 (1)
- AURORA B (1)
- AURORA C (1)
- AXL (1)
- B RAF (1)
- BCKDH KINASE (1)
- BMPR1A (1)
Species
Applications
Expression Hosts
Tags
Pathways
- MAPK signaling pathway (108)
- Neurotrophin signaling pathway (79)
- ErbB signaling pathway (70)
- Pathways in cancer (70)
- Focal adhesion (61)
- Chemokine signaling pathway (54)
- Insulin signaling pathway (54)
- GnRH signaling pathway (53)
- Progesterone-mediated oocyte maturation (49)
- Fc epsilon RI signaling pathway (48)
- T cell receptor signaling pathway (48)
- Toll-like receptor signaling pathway (46)
- Endocytosis (43)
- Pancreatic cancer (43)
- Colorectal cancer (42)
- Regulation of actin cytoskeleton (42)
- Prostate cancer (39)
- Axon guidance (37)
- Glioma (37)
- Wnt signaling pathway (34)
- Calcium signaling pathway (33)
- Fc gamma R-mediated phagocytosis (33)
- Non-small cell lung cancer (33)
- Oocyte meiosis (33)
- Gap junction (32)
- Adipocytokine signaling pathway (31)
- Endometrial cancer (31)
- Tight junction (31)
- VEGF signaling pathway (31)
- mTOR signaling pathway (31)
- Chronic myeloid leukemia (30)
- Melanoma (30)
- Acute myeloid leukemia (29)
- Adherens junction (29)
- Long-term potentiation (29)
- Vascular smooth muscle contraction (29)
- Epithelial cell signaling in Helicobacter pylori infection (28)
- Renal cell carcinoma (27)
- Apoptosis (26)
- B cell receptor signaling pathway (26)
- Melanogenesis (26)
- Type II diabetes mellitus (26)
- NOD-like receptor signaling pathway (25)
- Natural killer cell mediated cytotoxicity (22)
- Bladder cancer (20)
- Cell cycle (20)
- Cytokine-cytokine receptor interaction (19)
- Long-term depression (19)
- RIG-I-like receptor signaling pathway (19)
- TGF-beta signaling pathway (18)
- Small cell lung cancer (15)
- Hedgehog signaling pathway (14)
- Olfactory transduction (14)
- Prion diseases (14)
- Leukocyte transendothelial migration (13)
- Thyroid cancer (13)
- Alzheimer's disease (12)
- Jak-STAT signaling pathway (12)
- Dorso-ventral axis formation (10)
- p53 signaling pathway (9)
- Amyotrophic lateral sclerosis (ALS) (8)
- Viral myocarditis (8)
- Regulation of autophagy (7)
- Vibrio cholerae infection (7)
- Pathogenic Escherichia coli infection (6)
- Dilated cardiomyopathy (4)
- Hematopoietic cell lineage (4)
- PPAR signaling pathway (4)
- Primary immunodeficiency (4)
- Taste transduction (4)
- Cytosolic DNA-sensing pathway (3)
- Phosphatidylinositol signaling system (3)
- Basal cell carcinoma (2)
- Circadian rhythm - mammal (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Purine metabolism (2)
- Nucleotide excision repair (1)
- Parkinson's disease (1)
- Ubiquitin mediated proteolysis (1)